Intravenous 5-fluorouracil versus oral doxifluridine as preoperative concurrent chemoradiation for locally advanced rectal cancer: Prospective randomized trials

Medicine and Dentistry

• Arm 100%
• Fluorouracil 50%
• Toxicity 33%
• Neoplasm 33%
• Doxifluridine 33%
• Patient 33%
• Rectum Cancer 25%
• Radiation Therapy 25%
• Chemoradiotherapy 25%
• Spontaneous Remission 25%
• Recurrent Disease 16%
• Intravenous Drug Administration 16%
• Folinic Acid 16%
• Therapeutic Procedure 16%
• Surgery 8%
• Follow up 8%
• Infusion 8%
• Patient Compliance 8%
• Transrectal Ultrasonography 8%
• Gastrointestinal Toxicity 8%
• Preoperative Radiotherapy 8%
• Stomatitis 8%

Nursing and Health Professions

• Fluorouracil 50%
• Quality of Life 33%
• Neoplasm 33%
• Toxicity 33%
• Doxifluridine 33%
• Remission 25%
• Rectum Cancer 25%
• Chemoradiotherapy 25%
• Recurrent Disease 16%
• Chemotherapy 16%
• Intravenous Drug Administration 16%
• Folinic Acid 16%
• Surgery 8%
• Follow up 8%
• Transrectal Ultrasonography 8%
• Tumor Volume 8%
• Gastrointestinal Toxicity 8%
• Infusion 8%
• Patient Compliance 8%
• Procedures 8%
• Preoperative Radiotherapy 8%
• Stomatitis 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Fluorouracil 50%
• Neoplasm 33%
• Toxicity 33%
• Doxifluridine 33%
• Rectum Cancer 25%
• Remission 25%
• Recurrent Disease 16%
• Folinic Acid 16%
• Stomatitis 8%
• Gastrointestinal Toxicity 8%